US Drug Recall Register

FDA Drug Recalls

2,277 recalls · Class II, newest first

Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1161-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1159-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1158-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1157-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1156-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1155-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1154-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1153-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1152-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1151-2023
Class II · Moderate risk Ongoing

Humanrace Suncare

Reason Subpotent Drug: Product does not contain SPF that is declared on the label.

Humanrace D-1176-2023
Class II · Moderate risk Ongoing

Humanrace Suncare

Reason Subpotent Drug: Product does not contain SPF that is declared on the label.

Humanrace D-1175-2023
Class II · Moderate risk Ongoing

All Over-The-Counter

Reason CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Inmar Supply Chain Solutions, LLC D-1104-2023
Class II · Moderate risk Ongoing

Oxacillin for Injection

Reason Lack of Assurance of Sterility

Sagent Pharmaceuticals NDC 25021-163-99 D-0937-2023
Class II · Moderate risk Ongoing

Oxacillin for Injection

Reason Lack of Assurance of Sterility

Sagent Pharmaceuticals NDC 25021-162-24 D-0936-2023
Class II · Moderate risk Ongoing

Oxacillin for Injection

Reason Lack of Assurance of Sterility

Sagent Pharmaceuticals NDC 25021-146-10 D-0935-2023
Class II · Moderate risk Ongoing

Fingolimod Capsules

Reason Failed Dissolution Specifications

Ascend Laboratories, LLC NDC 67877-476-30 D-0925-2023
Class II · Moderate risk Ongoing

Tizanidine Hydrochloride Tablet 4mg

Reason Failed Stability Specifications

Preferred Pharmaceuticals, Inc. NDC 68788-7781-2 D-0894-2023